Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer

Ann Oncol. 2018 Mar 1;29(3):535-537. doi: 10.1093/annonc/mdy017.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Circulating Tumor DNA*
  • Drug Resistance, Neoplasm
  • Humans
  • Mutation
  • Protein Kinase Inhibitors

Substances

  • Circulating Tumor DNA
  • Protein Kinase Inhibitors